CTRI/2017/01/007684招募中2 期
A Randomized parallel group trial on a cohort on effectiveness of Ayurvedic treatment modalities in improving the disease free survival in carriers of BRCA 1/2 genes inbreast and ovarian cancer patients
Dr S P Sardeshmukh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Genetically predisposed patients (BRCA1/2 mutation carriers) with breast or ovarian cancer within 6 months to 1 year of diagnosis. During this period they would have completed conventional cancer treatment.Patients with stage I to IV of disease will be included
排除标准
- •Patients with BRCA1/2 mutation reporting 1 year and more after diagnosis will be excluded
研究者
相似试验
已完成
不适用
A clinical trial to study the effects of two surgical modalities of treatment, open pancreatoduodenectomy and laparoscopic pancreatoduodenectomy in patients with periampullary and pancreatic head cancers.CTRI/2013/09/004016Gem Hospital Research Centre Private Limited60
进行中（未招募）
2 期
A clinical trial on effectiveness of Ayurvedic medicines in improving the disease free survival and/or controlling recurrence of disease of breast cancer patients, whose cancer cells are negative for further hormonal treatment using complimentary Ayurvedic treatment.CTRI/2017/01/007690Dr Vasanti Godse
进行中（未招募）
2 期
A clinical trial to assess the effectiveness of Ayurvedic drugs to reduce toxic effects of chemotherapy and improving Quality of Life of breast cancer patientsCTRI/2017/01/007687Dr Vineeta Deshmukh
已完成
Unknown
A Randomized Parallel Group Trial to Evaluate the Impact of a Work Program Involving Snacks on Psychological Well-BeingJPRN-UMIN000049783Morinaga Seika Co. research institute312
已完成
3 期
Determining the effectiveness, safety and tolerability of Actoverco Filgrastim and Actoverco Pegfilgrastim compared to Neupogen in preventing the chemotherapy induced neutopenia in treatment of the breast cancerbreast cancer.breast cancerIRCT2013042212398N4Actoverco Pharmaceutic Company156